• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Around $4M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

    2/23/24 8:25:02 AM ET
    $BYON
    $EXEL
    $HPP
    $WTBA
    Catalog/Specialty Distribution
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $BYON alert in real time by email

    Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

    When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

    Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

    Beyond

    • The Trade: Beyond, Inc. (NYSE:BYON) Executive Chairman Marcus Lemonis acquired a total of 3,650 shares an average price of $27.17. To acquire these shares, it cost around $99,171.
    • What’s Happening: Beyond posted a wider-than-expected fourth-quarter loss on Feb. 20.
    • What Beyond Does: Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad range of products, including furniture, décor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items.

    West Bancorporation

    • The Trade: West Bancorporation, Inc. (NASDAQ:WTBA) CEO and President David D Nelson acquired a total of 2,007 shares at an average price of $17.55. To acquire these shares, it cost around $35,223.
    • What’s Happening: On Jan. 25, West Bancorp posted downbeat quarterly results.
    • What West Bancorporation Does: West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings, and money market accounts and time certificates of deposit.

    Don’t forget to check out our premarket coverage here

    Hudson Pacific Properties

    • The Trade: Hudson Pacific Properties, Inc. (NYSE:HPP) Director Barry A Sholem bought a total of 80,000 shares at an average price of $6.69. To acquire these shares, it cost around $535,200.
    • What’s Happening: On Feb. 12, Hudson Pacific Properties reported worse-than-expected fourth-quarter financial results.
    • What Hudson Pacific Properties Does: Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast.

    Exelixis

    • The Trade: Exelixis, Inc. (NASDAQ:EXEL) Director Caligan Partners LP Johnson bought a total of 190,000 shares at an average price of $20.70. The insider spent around $3.93 million to buy those shares.
    • What’s Happening: On Feb. 6, Exelixis posted upbeat quarterly earnings.
    • What Exelixis Does: Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer.

     

    Check This Out: Investor Optimism Improves Further; S&P 500 Settles At Record High

    Get the next $BYON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BYON
    $EXEL
    $HPP
    $WTBA

    CompanyDatePrice TargetRatingAnalyst
    West Bancorporation
    $WTBA
    4/6/2026$25.50Market Perform
    Hovde Group
    Hudson Pacific Properties Inc.
    $HPP
    1/9/2026$11.00Outperform → Market Perform
    BMO Capital Markets
    Exelixis Inc.
    $EXEL
    1/8/2026$48.00Overweight → Equal-Weight
    Morgan Stanley
    Exelixis Inc.
    $EXEL
    1/5/2026$41.00Neutral → Underperform
    BofA Securities
    Exelixis Inc.
    $EXEL
    11/18/2025Peer Perform
    Wolfe Research
    Exelixis Inc.
    $EXEL
    11/3/2025Buy → Neutral
    Guggenheim
    Exelixis Inc.
    $EXEL
    10/21/2025$48.00Market Perform → Outperform
    Leerink Partners
    Hudson Pacific Properties Inc.
    $HPP
    10/1/2025$3.50Overweight
    Cantor Fitzgerald
    More analyst ratings

    $BYON
    $EXEL
    $HPP
    $WTBA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hovde Group initiated coverage on West Bancorp with a new price target

    Hovde Group initiated coverage of West Bancorp with a rating of Market Perform and set a new price target of $25.50

    4/6/26 8:14:04 AM ET
    $WTBA
    Major Banks
    Finance

    Hudson Pacific Properties downgraded by BMO Capital Markets with a new price target

    BMO Capital Markets downgraded Hudson Pacific Properties from Outperform to Market Perform and set a new price target of $11.00

    1/9/26 8:49:40 AM ET
    $HPP
    Real Estate
    Finance

    Exelixis downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Exelixis from Overweight to Equal-Weight and set a new price target of $48.00

    1/8/26 8:39:35 AM ET
    $EXEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BYON
    $EXEL
    $HPP
    $WTBA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ferguson T Ritson

    4 - Hudson Pacific Properties, Inc. (0001482512) (Issuer)

    3/30/26 6:00:40 PM ET
    $HPP
    Real Estate
    Finance

    SEC Form 4 filed by Nelson David D

    4 - WEST BANCORPORATION INC (0001166928) (Issuer)

    3/26/26 4:30:25 PM ET
    $WTBA
    Major Banks
    Finance

    SEC Form 4 filed by Olafson Harlee

    4 - WEST BANCORPORATION INC (0001166928) (Issuer)

    3/26/26 4:29:42 PM ET
    $WTBA
    Major Banks
    Finance

    $BYON
    $EXEL
    $HPP
    $WTBA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Johnson David Edward bought $1,187,235 worth of shares (27,532 units at $43.12) (SEC Form 4)

    4 - EXELIXIS, INC. (0000939767) (Issuer)

    11/26/25 4:05:28 PM ET
    $EXEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Glaser Jonathan M bought $999,999 worth of shares (448,430 units at $2.23), increasing direct ownership by 204% to 668,699 units (SEC Form 4)

    4 - Hudson Pacific Properties, Inc. (0001482512) (Issuer)

    6/16/25 8:06:44 PM ET
    $HPP
    Real Estate
    Finance

    Director Harris Robert L Ii bought $100,000 worth of shares (44,843 units at $2.23), increasing direct ownership by 35% to 174,731 units (SEC Form 4)

    4 - Hudson Pacific Properties, Inc. (0001482512) (Issuer)

    6/16/25 8:06:35 PM ET
    $HPP
    Real Estate
    Finance

    $BYON
    $EXEL
    $HPP
    $WTBA
    SEC Filings

    View All

    SEC Form S-8 filed by Hudson Pacific Properties Inc.

    S-8 - Hudson Pacific Properties, Inc. (0001482512) (Filer)

    3/27/26 5:09:20 PM ET
    $HPP
    Real Estate
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by West Bancorporation

    SCHEDULE 13G/A - WEST BANCORPORATION INC (0001166928) (Subject)

    3/27/26 2:13:10 PM ET
    $WTBA
    Major Banks
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Hudson Pacific Properties Inc.

    SCHEDULE 13G/A - Hudson Pacific Properties, Inc. (0001482512) (Subject)

    3/27/26 9:51:22 AM ET
    $HPP
    Real Estate
    Finance

    $BYON
    $EXEL
    $HPP
    $WTBA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hudson Pacific Properties Announces Date for First Quarter Earnings Release and Conference Call

    Hudson Pacific Properties, Inc. (NYSE:HPP) today announced it will release first quarter financial results before market open on Thursday, May 7, 2026. The company will hold a conference call to discuss the results at 9:00 a.m. PT / 12:00 p.m. ET the same day. The conference call will be available via live audio webcast on the Investors section of the company's website at HudsonPacificProperties.com. A replay of the audio webcast will also be available following the call. About Hudson Pacific Properties Hudson Pacific Properties (NYSE:HPP) is a real estate investment trust serving dynamic tech and media tenants in global epicenters for these synergistic, converging and secular growth

    3/26/26 9:00:00 AM ET
    $HPP
    Real Estate
    Finance

    West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call

    WEST DES MOINES, Iowa, March 20, 2026 (GLOBE NEWSWIRE) -- West Bancorporation, Inc. (NASDAQ:WTBA) (the "Company"), parent company of West Bank, will report its results for the first quarter of 2026 on Thursday, April 23, 2026 before the markets open. The Company will discuss its results in a conference call scheduled for 2:00 p.m. Central Time on Thursday, April 23, 2026. The telephone number for the conference call is 800-715-9871. The conference ID for the conference call is 7846129. A recording of the call will be available until May 7, 2026, by dialing 800-770-2030. The conference ID for the replay call is 7846129, followed by the # key. West Bancorporation, Inc. is headquartered in

    3/20/26 8:30:00 AM ET
    $WTBA
    Major Banks
    Finance

    Hudson Pacific Properties Declares First Quarter 2026 Preferred Stock Dividend

    Hudson Pacific Properties, Inc. (NYSE:HPP) (the "Company") today announced that its Board of Directors has declared a dividend for the first quarter of 2026 on its 4.750% Series C cumulative preferred stock of $0.296875 per share, equivalent to an annual rate of $1.18750 per share, which will be paid on March 30, 2026 to preferred stockholders of record on March 20, 2026. About Hudson Pacific Properties Hudson Pacific Properties (NYSE:HPP) is a real estate investment trust serving dynamic tech and media tenants in global epicenters for these synergistic, converging and secular growth industries. Hudson Pacific's unique and high-barrier tech and media focus leverages a full-service, end-

    3/10/26 9:00:00 AM ET
    $HPP
    Real Estate
    Finance

    $BYON
    $EXEL
    $HPP
    $WTBA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for CABOMETYX issued to EXELIXIS INC

    Submission status for EXELIXIS INC's drug CABOMETYX (SUPPL-16) with active ingredient CABOZANTINIB S-MALATE has changed to 'Approval' on 09/20/2023. Application Category: NDA, Application Number: 208692, Application Classification: Labeling

    9/21/23 4:37:02 AM ET
    $EXEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for CABOMETYX issued to EXELIXIS INC

    Submission status for EXELIXIS INC's drug CABOMETYX (SUPPL-14) with active ingredient CABOZANTINIB S-MALATE has changed to 'Approval' on 07/14/2022. Application Category: NDA, Application Number: 208692, Application Classification: Efficacy

    7/15/22 4:38:40 AM ET
    $EXEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for CABOMETYX issued to EXELIXIS INC

    Submission status for EXELIXIS INC's drug CABOMETYX (SUPPL-12) with active ingredient CABOZANTINIB S-MALATE has changed to 'Approval' on 09/17/2021. Application Category: NDA, Application Number: 208692, Application Classification: Efficacy

    9/20/21 3:53:29 PM ET
    $EXEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BYON
    $EXEL
    $HPP
    $WTBA
    Leadership Updates

    Live Leadership Updates

    View All

    Hudson Pacific Appoints Jon Bortz to Board of Directors

    Hudson Pacific Properties, Inc. (NYSE:HPP), a unique provider of end-to-end real estate solutions for tech and media tenants, today announced the election of Jon Bortz to the company's Board of Directors, and the retirement of Jonathan Glaser, both effective December 2, 2025. Bortz is the Founder, Chairman & CEO of Pebblebrook Hotel Trust (NYSE:PEB), which he launched in 2009 and grew into the largest owner of urban and resort lifestyle hotels in the U.S. He also founded and serves as Chairman of the Curator Hotel & Resort Collection, a collection of boutique and lifestyle independent hotels and resorts. Before that, Bortz founded LaSalle Hotel Properties (NYSE:LHO), serving as CEO and lat

    12/3/25 9:00:00 AM ET
    $HPP
    $PEB
    Real Estate
    Finance
    Real Estate Investment Trusts

    The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners

    DIAMOND BAR, Calif., Oct. 21, 2025 /PRNewswire/ -- The Institute for Follicular Lymphoma Innovation (IFLI), a global, non-profit, private foundation dedicated to accelerating the development of innovative treatment options for patients with follicular lymphoma (FL)., today announced the appointments of Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners. "I believe Carol and Mehrdad will be exceptional partners to the IFLI team and portfolio as they bring decades of strategic leadership and drug development expertise," said David McCullagh, Man

    10/21/25 8:05:00 AM ET
    $CRVS
    $DNA
    $EXEL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    Hudson Pacific Appoints T. Ritson Ferguson to Board of Directors

    Hudson Pacific Properties, Inc. (NYSE:HPP), a unique provider of end-to-end real estate solutions for tech and media tenants, today announced the election of T. Ritson Ferguson to the company's Board of Directors, and the retirement of Director Mark D. Linehan, both effective September 11, 2025. Ferguson is an Independent Investment Committee Member of CBRE Investment Management (CBREIM) Listed Real Assets. He previously served as Global CEO and Global CIO of CBREIM, as well as Vice Chairman, CEO and CIO of Listed Real Assets, where he oversaw the firm's evolution into a leading global real assets investment manager. Ferguson is also Vice Chair and Audit Committee member of the Duke Unive

    9/15/25 9:00:00 AM ET
    $HPP
    $IGR
    Real Estate
    Finance
    Finance Companies

    $BYON
    $EXEL
    $HPP
    $WTBA
    Financials

    Live finance-specific insights

    View All

    Hudson Pacific Properties Announces Date for First Quarter Earnings Release and Conference Call

    Hudson Pacific Properties, Inc. (NYSE:HPP) today announced it will release first quarter financial results before market open on Thursday, May 7, 2026. The company will hold a conference call to discuss the results at 9:00 a.m. PT / 12:00 p.m. ET the same day. The conference call will be available via live audio webcast on the Investors section of the company's website at HudsonPacificProperties.com. A replay of the audio webcast will also be available following the call. About Hudson Pacific Properties Hudson Pacific Properties (NYSE:HPP) is a real estate investment trust serving dynamic tech and media tenants in global epicenters for these synergistic, converging and secular growth

    3/26/26 9:00:00 AM ET
    $HPP
    Real Estate
    Finance

    West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call

    WEST DES MOINES, Iowa, March 20, 2026 (GLOBE NEWSWIRE) -- West Bancorporation, Inc. (NASDAQ:WTBA) (the "Company"), parent company of West Bank, will report its results for the first quarter of 2026 on Thursday, April 23, 2026 before the markets open. The Company will discuss its results in a conference call scheduled for 2:00 p.m. Central Time on Thursday, April 23, 2026. The telephone number for the conference call is 800-715-9871. The conference ID for the conference call is 7846129. A recording of the call will be available until May 7, 2026, by dialing 800-770-2030. The conference ID for the replay call is 7846129, followed by the # key. West Bancorporation, Inc. is headquartered in

    3/20/26 8:30:00 AM ET
    $WTBA
    Major Banks
    Finance

    Hudson Pacific Properties Declares First Quarter 2026 Preferred Stock Dividend

    Hudson Pacific Properties, Inc. (NYSE:HPP) (the "Company") today announced that its Board of Directors has declared a dividend for the first quarter of 2026 on its 4.750% Series C cumulative preferred stock of $0.296875 per share, equivalent to an annual rate of $1.18750 per share, which will be paid on March 30, 2026 to preferred stockholders of record on March 20, 2026. About Hudson Pacific Properties Hudson Pacific Properties (NYSE:HPP) is a real estate investment trust serving dynamic tech and media tenants in global epicenters for these synergistic, converging and secular growth industries. Hudson Pacific's unique and high-barrier tech and media focus leverages a full-service, end-

    3/10/26 9:00:00 AM ET
    $HPP
    Real Estate
    Finance

    $BYON
    $EXEL
    $HPP
    $WTBA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Beyond Inc.

    SC 13G/A - BEYOND, INC. (0001130713) (Subject)

    11/14/24 5:05:30 PM ET
    $BYON
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Beyond Inc.

    SC 13G/A - BEYOND, INC. (0001130713) (Subject)

    11/12/24 1:32:09 PM ET
    $BYON
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Beyond Inc.

    SC 13G/A - BEYOND, INC. (0001130713) (Subject)

    11/4/24 10:23:07 AM ET
    $BYON
    Catalog/Specialty Distribution
    Consumer Discretionary